Proton Pump Inhibitors

Proton Pump Inhibitors Could Make It Harder To Treat GI Cancers, New Study Shows

Recently, we reported on troubling research that found a link between proton pump inhibitor drugs, the world’s most popular medications for heartburn, and gastrointestinal cancer. In a wide-ranging study of nearly 63,500 patients, a group of physicians from the University of Hong Kong concluded that, for those patients who received a proton pump inhibitor as… read more

Read More

Hong Kong Researchers Find Higher Risk Of Gastrointestinal Cancer In PPI Patients

Long-term proton pump inhibitor use has been associated with an increased risk for gastrointestinal cancer, according to a new study from researchers at the University of Hong Kong. Analyzing data from nearly 63,400 patients, the study’s authors found a 2.44 increased risk for gastric cancer among patients who had taken one of the popular heartburn… read more

Read More

Washington University Researchers Find Higher Death Risk In PPI Patients

Writing in the British Medical Journal (BMJ), researchers from Washington University in St. Louis have linked proton pump inhibitors, some of the world’s most commonly-used medications, to an increased risk of death. Do PPI Health Dangers Increase Risk Of Death? In recent years, the heartburn drugs, which include bestsellers like Nexium and Prevacid, have been associated… read more

Read More